López Fernando, Lund Valerie J, Suárez Carlos, Snyderman Carl H, Saba Nabil F, Robbins K Thomas, Vander Poorten Vincent, Strojan Primož, Mendenhall William M, Rinaldo Alessandra, Ferlito Alfio
Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias and CIBERONC, ISCIII, Oviedo, Spain.
Adv Ther. 2017 Oct;34(10):2181-2198. doi: 10.1007/s12325-017-0605-9. Epub 2017 Sep 4.
The management of sinonasal cancer is a challenge due to its low occurrence and anatomical and significant diversity of histological types. The therapeutic modality used should be tailored individually according to the histology, tumour stage, molecular profile and previous treatments. The clinical management of sinonasal cancer has improved greatly owing to developments in endoscopic surgery and precision radiotherapy. Complete surgical resection is the mainstay of sinonasal malignancies' management but multimodality therapy is associated with improved outcomes in certain histologies. The recognition of various histological types with biological behaviours more suitable for non-surgical modalities has allowed treatment protocols to become more tailored to the disease. In this review we aim to describe and to summarise the current data guiding the management of sinonasal cancer with emphasis on phenotypic variation.
由于鼻窦癌发病率低,且组织学类型在解剖学上存在显著差异,其管理颇具挑战。所采用的治疗方式应根据组织学、肿瘤分期、分子特征和既往治疗情况进行个体化调整。由于内镜手术和精确放疗的发展,鼻窦癌的临床管理有了很大改善。完整的手术切除是鼻窦恶性肿瘤管理的主要手段,但多模式治疗在某些组织学类型中与更好的预后相关。认识到各种具有更适合非手术治疗方式生物学行为的组织学类型,使得治疗方案能够更针对该疾病进行定制。在本综述中,我们旨在描述和总结指导鼻窦癌管理的当前数据,重点关注表型变异。